Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Eli Lilly and Co NYSE:LLY accuses Federal Health Agency in lawsuit over hospital drug discounts

November 18, 2024
Eli Lilly and Company, a renowned pharmaceutical giant, has recently filed a lawsuit against the Federal Health Agency regarding their hospital drug discounting program. The company alleges that the agency wrongfully rejected changes proposed by Eli Lilly and Johnson & Johnson, another major pharmaceutical company. This legal battle has sent shockwaves through the industry, causing Eli Lilly's stock to plummet more than 10% in just a month. Investors are now left wondering whether to buy, sell, or hold onto the company's stock. For a professional prognosis on the future movement of Eli Lilly's stock, it is recommended to consult experts at Stocks Prognosis.
If you want to leave a comment, then you need Login or Register





Other data for LLY

Related data

LLYAugust 12, 2025Eli Lilly and Co LLY Traded Lower in Q2 Despite Good Results  ~1 min.

Eli Lilly and Company, despite reporting good results in the second quarter of this year, saw its stock price traded lower....


LLYAugust 8, 2025ELI LILLY AND COMPANY Stock Hits Price Target Forecast with Profit of 18.31%  ~1 min.

ELI LILLY AND COMPANY stock has successfully achieved the price target forecast set by QuantWave with a profit of 18.31%. The forecast, which indicated a short position on June 4, 2025, at a price of 764....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Forecasted Price Target with 20.09% Profit: QuantWave Achieves Success  ~1 min.

On January 28, 2025, QuantWave, an automated forecasting platform, issued a short signal for ELI LILLY AND COMPANY stock when it was trading at 800.2 $....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits QuantWave Forecast, Delivering 19.57% Profit  ~1 min.

ELI LILLY AND COMPANY has achieved the price target forecast set by QuantWave, signaling a 19.57% profit for investors....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Price Target Forecast as QuantWave Users Gain 17.38% Profit  ~1 min.

ELI LILLY AND COMPANY stock recently achieved the price target forecast set by QuantWave, marking a significant success for users of the automated forecasting platform....


LLYAugust 7, 2025ELI LILLY AND COMPANY Hits Forecast Profit of 23.55%: A Success Story for QuantWave  ~2 min.

ELI LILLY AND COMPANY, a prominent player in the pharmaceutical industry, recently achieved a significant milestone by hitting a price target forecast generated by the innovative forecasting platform, QuantWave. The forecast, which indicated a short direction signal on April 17, 2025, at a price of 836.4 USD, proved to be accurate as the stock reached the predicted target price of 639.46 USD on Au...


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Forecast Price Target with 22.13% Profit - QuantWave Achieves Success in Stock Prediction  ~2 min.

ELI LILLY AND COMPANY stock recently reached the forecast price target set by QuantWave, resulting in a profit of 22.13%....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Price Target Forecast, Generating 17.25% Profit  ~1 min.

ELI LILLY AND COMPANY stock has successfully achieved the price target forecast set by QuantWave, reaching a profit of 17.25%. The forecast signal was issued on April 30, 2024, with the stock price at $772....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Short Price Target Forecast with 19.15% Profit  ~1 min.

On December 24, 2024, QuantWave, the automated forecasting platform, issued a short signal for ELI LILLY AND COMPANY stock when it was priced at 790.94 $....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Price Target Forecast with 22.51% Profit for QuantWave Users  ~2 min.

ELI LILLY AND COMPANY, a prominent pharmaceutical company, recently achieved the price target forecast set by QuantWave, an automated forecasting platform, resulting in a profitable outcome for investors. The forecast signal was generated on 8th November 2024 when the stock was priced at 825.23 $. The prediction indicated a short direction, and on 7th August 2025, the target price of 639.46 $ was ...


VRTXJanuary 2, 2025Vertex Pharmaceuticals Incorporated: Promising Future Ahead  ~1 min.

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) is gaining attention in the options market, with predictions of a potential spike in its stock. Brokerages have set a price target of $494....


VRTXJanuary 29, 2025Brighton Jones LLC Increases Stake in Vertex Pharmaceuticals VRTX  ~1 min.

Brighton Jones LLC, a prominent investment firm, has recently revealed that it has increased its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)....


VRTXMarch 22, 2025Vertex Pharmaceuticals VRTX: One of the Best Biotech Stocks to Buy According to Billionaires  ~2 min.

Vertex Pharmaceuticals Incorporated (VRTX) has been recognized as one of the top biotech stocks to invest in by billionaires....


VRTXFebruary 10, 2025Vertex Pharmaceuticals Announces Breakthrough FDA Approval  ~1 min.

Vertex Pharmaceuticals has recently received a major FDA approval for its groundbreaking drug. This approval is expected to have a significant impact on the company's future and its stock value....


VRTXJanuary 1, 2025Vertex Pharmaceuticals Inc. (VRTX) Sees Options Market Predicting a Spike  ~1 min.

Shares of Vertex Pharmaceuticals Inc. (VRTX) are expected to experience a significant increase, according to the options market....